In vivo pharmacokinetics of a gentamicin-loaded col-lagen sponge in acute periprosthetic infection Serum values in 19 patients

Acta Orthopaedica

Volumn 79, Issue 5, 2008, Pages 637-642

  Swieringa, Anne J ^a   Goosen, Jon H M ^a   Jansman, Frank G A ^b   Tulp, Niek J A ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COLLAGEN; DRUG VEHICLE; GENTAMICIN;

ACUTE DISEASE; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; HIP ARTHROPLASTY; HUMAN; INFECTION; KNEE ARTHROPLASTY; MICROBIOLOGY; MIDDLE AGED; OSTEOMYELITIS; VEHICLES;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; COLLAGEN; GENTAMICINS; HUMANS; MIDDLE AGED; OSTEOMYELITIS; PROSTHESIS-RELATED INFECTIONS; VEHICLES;

EID: 53449100966     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670810016650     Document Type: Note

References (31)

1. Antti-Poika I, Josefsson G, Konttinen Y T, Lidgren L, San-tavirta S, Sanzen L. Hip arthroplasty infections. Current concepts. Acta Orthop Scand 1990; 61 (2): 163-9,
2. Bálint L, Kocsis B, Szántó Z, Szabó G. In vitro measurement of the time-related efficacy of gentamicin sulfate release from bone cements. Chemotherapy 2004; 50:302-7.
3. Blanc C H. Expérience clinique avec les éponges collagène-Garamycin. In: Cahiers d’enseignement de la SOFCOT 37, L’ infection en chirurgie orthopédique (ed. Duparc J). Expansion Scientifique Française, Paris 1992; 37: 186-90.
4. Brown M R W, Collier P J, Gilbert P. Influence of growth rate on susceptibility to antimicrobial agents: modifica-tion of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother 1990; 34: 1623-8.
5. Buchholz H W, Elson R A, Engelbrecth E, Lodenkamper H, Rotter J, Siegel A. Management of deep infection of total hip arthroplasty. J Bone Joint Surg (Br) 1982; 63: 342-53.
6. Cockcroft D W, Gault N H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31-41.
7. Diefenbeck M, Mückley T, Hofmann G O. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury 2006; 37: S95-104.
8. Firsov A A. Biodegradable implants containing gentamicin: Drug release and pharmacokinetics. Drug Development and Industrial Pharmacy Drug Dev Ind Pharm 1987; 13: 1651-74.
9. Habash M, Reid G. Microbial biofilms: Their development and significance for medical device-related infections. J Clin Pharmacol 1999; 39: 887-98.
10. Isselbacher K J, Braunwals E, Wilson J D, Martin J B, Fauci A I, Kasper D L. Harrison’s internal medicinie, 13th edi-tion. McGraw Hill Inc. 1994.
11. Jorgensen L G, Sorensen T S, Lorentzen J E. Clinical and pharmacokinetic evaluation of gentamycin containing collagen in groin wound infections after vascular recon-struction. Eur J Vasc Surg 1991; 5 (1): 87-91.
12. Leggett J E, Fantin B, Ebert S, Totsuka K, Vogelman B, Calame W, Mattie H, Craig W A. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J Infect Dis 1989; 159: 281-91.
13. Letsch R, Rosenthal E, Joka T. Local antibiotic adminis-tration in osteomyelitis treatment: A comparative study with two different carrier substances. Aktuelle Traumatol 1993; 23 (7): 324-9.
14. Lorentzen H, Kallehave F, Kolmos H J, Knigge U, Bulow J, Gottrup F. Gentamicin concentrations in human subcu-taneous tissue. Antimicrob Agents Chemother 1996; 40 (8): 1785-9.
15. Mehta S, Humphrey J S, Schenkman D I. Gentamicin dis-tribution from a collagen carrier. J Orthop Res 1996; 14: 749-54.
16. Miclau T, Dahners L E, Lindsey R W. In vitro pharmaco-kinetics of anibiotic releaase from locally implantable materials. J Orthop Res1993; 11: 627-32.
17. Moore R D, Lietman P S, Smith C R. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987; 155: 93-9.
18. Neut D, van de Belt H, Stokroos I, van Horn J R, van der Mei H C, Busscher H J. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 2001; 47 (6): 885-91.
19. Servais H, Jossin Y, Van Bambeke F, Tulkens P M, Mingeot-Lecrerq M P. Gentamycin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electropora-tion. Antimicrob Agents Chemother 2006; 50: 1213-21.
20. Siber G R, Echeverria P, Smith A L, Paisley J W, Smith D H. Pharmacokinetics of gentamicin in children and adults. J Infect Dis 1975; 132 (6): 637-51.
21. Smyth E T M, Emmerson A M. Surgical site infection surveillance review. J Hosp Infect 2000; 45: 173-84.
22. Sørensen T S, Sørensen A I, Merser S. Rapid release of gen-tamicin from collagen sponge. Acta Orthop Scand 1990; 61 (4): 353-6.
23. Swieringa A J, Tulp N J A. Toxic serum gentamicin levels after the use of gentamicin loaded sponges in infected total hip arthroplasty. Acta Orthop 2005 76 (1): 75-7.
24. Von Hasselbach C. Clinical aspects and pharmacokinetics of collagen-gentamicin as adjuvant local therapy of osseous infections. Unfallchirurg 1989; 92 (9): 459-70.
25. Wachol-Drewek Z, Pfeiffer M, Scholl E. Comparative inves-tigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 1996; 17 (17): 1733-8.
26. Wahlig H, Dingeldein E, Bergmenn R, Reuss K. The release of gentamcin from polymethylmethacrylate beads. J Bone Joint Surg (Br) 1978; 60: 270-5.
27. Walenkamp G. Small PMMA beads improve gentamicin release. Acta Orthop Scand 1989; 60: 668-9.
28. Walenkamp G, Karsemaker S. Pharmacokinetics of two gentamicin collagen fleeces in animal experiments (ed. Walenkamp GHIM). Biomaterials in surgery. Stuttgart, New York: Georg Thieme Verlag 1998: 18-20.
29. Wernet E, Ekkernkamp A, Jellestad H, Muhr G. Antibi-otic-containing collagen sponge in therapy of osteitis. Unfallchirurg 1992; 95 (5): 259-64.
30. Witsø E, Persen L, Benum P, Aamodt A, Husby O S, Bergh K. High local contrations without systemic adverse events after impaction of netilmicin-impregnated bone. Acta Orthop Scand 2004; 75; 339-46.
31. Young L S, Hewitt W L. Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and staphylococcus aureus. Antimicrob Agents Chemother 1973; 4 (6): 617-25.